ShanX Medtech (SXM), which provides in-vitro diagnostic platforms for antibiotic susceptibility testing
ShanX Medtech has raised €15M across 1 funding round from 6 investors, most recently a Seed round in Jan 2026. Based in Eindhoven, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-08 | Seed | €15M |
| Borski Fund,Brabantse Ontwikkelings Maatschappij (BOM),CbusineZ,Invest-NL,NextGen Ventures,prominent strategic angel fund |
| View deal → |
